Rifaximin versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients having Cirrhosis of Liver. mfm. 2024;28(12). Accessed January 31, 2026. https://medicalforummonthly.com/index.php/mfm/article/view/4304